×
About 913 results

ALLMedicine™ Fructosamine Center

Research & Reviews  291 results

A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes
https://clinicaltrials.gov/ct2/show/NCT02053272

Dec 20th, 2022 - This 14 week (one week baseline, 12 week treatment period and one week follow-up), multicentre, randomised, double blind, placebo controlled, parallel group study will evaluate the efficacy, safety and tolerability of 2, 5 and 15 mg of GWP42004 as...

Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 s...
https://doi.org/10.1016/j.jconrel.2022.12.012
Journal of Controlled Release : Official Journal of the C... Ganugula R, Nuthalapati NK et. al.

Dec 13th, 2022 - Treatments for diabetic kidney disease (DKD) mainly focus on managing hyperglycemia and hypertension, but emerging evidence suggests that inflammation also plays a role in the pathogenesis of DKD. This 10-week study evaluated the efficacy of daily...

Glucose Monitoring During Chemotherapy
https://clinicaltrials.gov/ct2/show/NCT04473378

Nov 18th, 2022 - This is a prospective observational cohort study monitoring trends in glucose in patients with early stage breast cancer treated with neoadjuvant or adjuvant chemotherapy. Patients will wear a noninvasive glucose monitoring sensor, the Freestyle L...

Bile Acids in Acute Insulin Resistance
https://clinicaltrials.gov/ct2/show/NCT05571670

Oct 10th, 2022 - The primary objective of this study is to determine the effect of drug-induced acute insulin resistance (diaIR) on the ratio of 12α-hydroxylated bile acids (12-HBA) to 12α-hydroxylated bile acids (non-12-HBA) in cancer patients treated with phosph...

Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment
https://clinicaltrials.gov/ct2/show/NCT03505762

Oct 10th, 2022 - PRIMARY OBJECTIVES: I. To compare the cumulative incidence of hyperglycemia after 3 cycles of treatment between standard or tailored rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate and prednisone (R-CHOP) chemotherapy. ...

see more →

Clinicaltrials.gov  60 results

A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes
https://clinicaltrials.gov/ct2/show/NCT02053272

Dec 20th, 2022 - This 14 week (one week baseline, 12 week treatment period and one week follow-up), multicentre, randomised, double blind, placebo controlled, parallel group study will evaluate the efficacy, safety and tolerability of 2, 5 and 15 mg of GWP42004 as...

Glucose Monitoring During Chemotherapy
https://clinicaltrials.gov/ct2/show/NCT04473378

Nov 18th, 2022 - This is a prospective observational cohort study monitoring trends in glucose in patients with early stage breast cancer treated with neoadjuvant or adjuvant chemotherapy. Patients will wear a noninvasive glucose monitoring sensor, the Freestyle L...

Bile Acids in Acute Insulin Resistance
https://clinicaltrials.gov/ct2/show/NCT05571670

Oct 10th, 2022 - The primary objective of this study is to determine the effect of drug-induced acute insulin resistance (diaIR) on the ratio of 12α-hydroxylated bile acids (12-HBA) to 12α-hydroxylated bile acids (non-12-HBA) in cancer patients treated with phosph...

Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment
https://clinicaltrials.gov/ct2/show/NCT03505762

Oct 10th, 2022 - PRIMARY OBJECTIVES: I. To compare the cumulative incidence of hyperglycemia after 3 cycles of treatment between standard or tailored rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate and prednisone (R-CHOP) chemotherapy. ...

Healthy Food Prescription Incentive Program
https://clinicaltrials.gov/ct2/show/NCT04725630

Sep 28th, 2022 - It is vital for individuals with type 2 diabetes (T2DM) to adhere to a healthy dietary pattern to maintain optimal blood glucose levels and overall health. However, the increasing costs of healthy foods is a barrier to maintaining healthful dietar...

see more →

News  14 results

Substance in Tears Could Be Used for Diabetes Monitoring
https://www.medscape.com/viewarticle/939359

Oct 19th, 2020 - Dr Masakazu Aihara Measuring glycated albumin (glycoalbumin, GA) in tears could be a future way for those with diabetes to monitor their blood sugar levels noninvasively. In a 100-patient trial, levels of GA in tears were found to be strongly corr...

Substance in tears could be used for diabetes monitoring
https://www.mdedge.com/endocrinology/article/230120/diabetes/substance-tears-could-be-used-diabetes-monitoring
Sara Freeman

Oct 16th, 2020 - Measuring glycated albumin (glycoalbumin, GA) in tears could be a future way for those with diabetes to monitor their blood sugar levels noninvasively. Dr.

HbA1c, OGTT, Fasting Glucose & More: How to Pick Best T2D Screener
https://www.medpagetoday.com/endocrinology/diabetes/73545

Jun 18th, 2018 - Clinicians can face several challenges when screening patients for type 2 diabetes. In this exclusive video, Susan E. Spratt, MD, of Duke University Medical Center in North Carolina, breaks down when to use an HbA1c test and when you need to pivot...

New Risk Prediction Method for Gestational Diabetes
https://www.medpagetoday.com/endocrinology/diabetes/62013

Dec 12th, 2016 - Simple metrics, including biomarker and anthropometric measures, accurately identified gestational diabetes risk among women with obesity, researchers reported. Lead author of the study, Sara White, MRCP, of King's College in London, said in a pre...

Why Do Black Americans Have Higher A1c Levels Than Whites?
https://www.medscape.com/viewarticle/867325

Aug 17th, 2016 - I am part of a team that is trying to answer what I believe is an important clinical question: Do blacks Americans have higher A1c levels than white Americans, and if they do, why. This has been a controversy for the past decade or so What did we ...

see more →